Against the backdrop of the COVID-19 pandemic, the Canadian pharma market landscape continues to transform at an extraordinary pace.
At the 20th Annual Market Access Summit, you will gain exclusive insights into the patient perspective. This knowledge will help you optimize your market access strategies and ensure that your product launches are successful. Position your organization as an industry leader with expertise from senior pharma market professionals. Benchmark best practices to navigate the new CADTH drug review process. Ensure compliance with the amended PMPRB pricing regulations coming into force July 2021. Prepare for the impact of a new provincial approach that will increase the use of biosimilars.
Hear from regulators and companies like CADTH, pCPA, AbbVie, Pfizer, Boehringer Ingelheim, Eli Lilly and more!
Take advantage of this unique opportunity to network with your pharma market peers in an interactive learning environment. Develop innovative strategies with the help of market access experts to ensure you emerge from the pandemic more successful than ever.